PJSC «PROMOMED» is a leading innovative biopharmaceutical company with significant growth potential in promising segments of the pharmaceutical market. The company’s structure includes its own unique world-class R&D center and a high–tech manufacturing facility — «BIOKHIMIK» plant. Thanks to this, PROMOMED implements the full-cycle production concept «from idea to molecule, from molecule to patient». The company is developing a diversified portfolio of over 370 medicines in the top 10 segments of the pharmaceutical market, including those that have no analogues in Russia. Based on its own developments, PROMOMED produces drugs for the treatment of socially significant diseases: oncological, neurological, rheumatic, infectious disease, diabetes mellitus, obesity, and others. The company is an active participant in the system ensuring national drug security and import independence.